Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody | Patent Number 10961307

US 10961307 B2
Application Number16580509
Publication NumberUS 20200095315 A1
Pendency1 year, 6 months, 8 days
Filled DateSep 24, 2019
Priority DateSep 24, 2018
Publication DateMar 26, 2020
Expiration DateSep 23, 2038
Inventor/ApplicantsColleen Marano
Christopher O'Brien
Omoniyi Adedokun
Kimberly Shields-Tuttle
Katherine Li
Richard Strauss
Hongyan Zhang
Jewel Johanns
Jewel Johans
ExaminesLANDSMAN, ROBERT S
Art Unit1647
Technology Center1600
Assignments
Johnson & Johnson
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.